deaths from compounded semaglutide Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

Recent reports link around 10 deaths and 100 hospitalizations in the U.S. to compounded versions of semaglutide, sold under the brand name Ozempic by Novo Nordisk. The company has raised concerns with

29.06

★★★★☆4.8 (126)

Semaglutide Compounding Safety Concerns: 10 Deaths Reported - European Medical Journal Semaglutide Compounding Safety Concerns: 10 Deaths Reported

27.89

★★★★★4.9 (98)

Off-Label Semaglutide Linked to Deaths, Hospitalizations Calling for Compounding Regulation

21.12

★★★★★5.0 (157)

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications,

29.28

★★★★★4.7 (84)

We're warning consumers of concerns with compounded medications containing semaglutide: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing- semaglutide-marketed-type-2-diabetes-or-weight-loss

29.83

★★★★★4.9 (203)

Semaglutide: The Drug of Today and a Steppingstone to Tomorrow

29.33

★★★★★5.0 (176)

Estimating the lives that could be saved by expanded access to weight-loss drugs

25.50

★★★★★4.8 (132)